Dermira’s $193.8 Million Follow-On Offering

Fenwick & West represented Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the…

This content is for members only.
Login to Read More Join Now

PrintFriendly

Sami Health’s $18 Million Series B Funding Round

Gurnet Point Capital’s Acquisition of Paratek Pharmaceuticals

City of Colorado Springs’ $21 Million Bond Offering

Banco Bradesco’s R$418 Million Bank Guarantees Issuance

Yacopini Mirai’s AR$100 Million Notes Offering

SYOS’ Investment Round

OIEG’s EUR600M Private Offering of Senior Notes

Capital One Financial Corporation’s Acquisition of Velocity Black

BCI’s Minority Investment in ZEDRA

Telecom Egypt SAE’s Sale of Shares on the Secondary Market at EGX

Scatec’s Joint Development Agreement with Alexandria National Refining and Petrochemicals Company

FMO and CAP’s Co-Investment in Merensky Timber

Majid Al Futtaim’s $500 Million Green Sukuk Offering

AnD Ventures’ $70 Million Fund Raising

G1 Group’s Acquisition of Mizug Plus

Kuala Linggi International Port’s Agreement with CCCC Dredging Southeast Asia

Salter Brothers’ Acquisition of Five Luxury Retreats from the Escarpment Group

Liverpool Partners’ Acquisition of Simplyai

Linklaters bolsters corporate practice in Hong Kong SAR with hire of Roger Cheng

Osborne Clarke Adds Notarial Services to its Berlin Office

Rebecca Leon Returns to Holland & Knight to Co-Lead Broker-Dealer Regulation and Compliance Team

Presumption of “Tax Inversion”: The Italian Supreme Court Clarifues That “Mediated” Control Is Not Relevant

Italian DPA: Company Fined For Failure To Monitor Its Suppliers

The (Un)Happy Relationship Between SIAE And Meta in Italy

A new Governance for Arendt

Linklaters bolsters corporate practice in Hong Kong SAR with hire of Roger Cheng

Osborne Clarke Adds Notarial Services to its Berlin Office

Dermira’s $193.8 Million Follow-On Offering

Author: Ambrogio Visconti